SAGE Therapeutics, Inc. (SAGE)

71.51
NASDAQ
Prev Close 70.82
Day Low/High 70.33 / 72.10
52 Wk Low/High 25.01 / 155.33
Exchange NASDAQ
Shares Outstanding 51.97B
Market Cap 3.68B
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

M&A Appetite in Pharma Has Proved Potent: Chart of the Day

M&A Appetite in Pharma Has Proved Potent: Chart of the Day

With total deals trending toward hundreds of billions, investors may be eager to bet on who's next to be acquired.

A Big Outside Day and Lower Close on Sage Therapeutics Looks Bearish to Me

A Big Outside Day and Lower Close on Sage Therapeutics Looks Bearish to Me

Let's review the charts this morning.

Jim Cramer: Innovation Is on Display at the J.P. Morgan Healthcare Conference

Jim Cramer: Innovation Is on Display at the J.P. Morgan Healthcare Conference

We're out in San Francisco this week covering the amazing innovations that so many companies reveal at this annual conference.

Sage Therapeutics Turned Down - Don't Rush to Be a Buyer

Sage Therapeutics Turned Down - Don't Rush to Be a Buyer

Let's see what the charts and indicators look like.

Jim Cramer: Investors Pull Into the FANG Rest Stop

Jim Cramer: Investors Pull Into the FANG Rest Stop

When rotations slow or pause, investors return to the new classics.

Final Hour Starts in the Green

3pm blog update Heading into the homestretch of the trading week. All the major indices remain firmly in the green. Small biotech is having a very strong day, up about two percent this Friday. Some small cap movers today. Synergy Pharmaceuticals nic...

Sage Therapeutics Skyrockets on Data for Depression Drug -- Biotech Movers

Sage Therapeutics Skyrockets on Data for Depression Drug -- Biotech Movers

The Cambridge, Mass.-based firm unveiled positive top-line results from its Phase 2 study of SAGE-217 in patients with moderate to severe major depressive disorder.

The Dip Buyers Have Simply Been a Bit Slow

The Dip Buyers Have Simply Been a Bit Slow

But if they start to weaken, be ready to make some adjustments fast.

Sage Skyrockets on Postpartum Depression Drug Studies Data -- Biotech Movers

Sage Skyrockets on Postpartum Depression Drug Studies Data -- Biotech Movers

The Cambridge, Mass.based firm unveiled positive top-line results from a pair of Phase 3 studies of brexanolone in postpartum depression.

The Good, the Bad and the Ugly (Monday Edition)

"If you work for a living, why do you kill yourself working?" -- Tuco, The Ugly: "The Good, the Bad and the Ugly" There was plenty of sector rotation today (but little overall movement), so let's move to the abbreviated Monarch Notes form of "Takeaw...

Tuesday Swoon Won't Change Most People's Market Views

I have little to add to my opening missive and what I have been saying for months -- that the markets have under priced risk and that the potential downside may dramatically exceed upside opportunity and reward (by about a factor of 3.5x).   Today's...

My Takeaways and Observations

"I never knew how easy the game of baseball was until I entered the broadcasting booth." -- Mickey Mantle While the markets were relatively flat there was a lot of subsurface action.   The Alternative to the Bullish View. I might be right I might be...

My Takeaways and Observations

"I'd unravel every riddle for any individ'le, In trouble or in pain. With the thoughts I'd be thinkin' I could be another Lincoln If I only had a brain." -- "If I Only Had A Brain" (Harold Arlen and E.Y. Harburg), from "The Wizard of Oz" I believe I...

Biowreck!

I am not sure if this has broader consequences, but biotech (especially of a speculative -- kind) is spitting the bit, again today.   I have already mentioned Allergan AGN (which I am buying now). Celgene CELG and Gilead Sciences GILD can't rally ei...

Takeaways and Observations

"She's a witch of trouble in electric blue, In her own mad mind she's in love with you. With you. Now what you gonna do? Strange brew, kill what's inside of you." -- Cream, Strange Brew     Strange brew!    You have probably forgotten October, 1987....

Takeaways and Observations

"I understand that there's a certain comfort in crowds, as well as a distrust of the remnants of individual opinion. I suppose that's a function of the human condition, human spirit and human nature." -- Kass Diary, "You Gotta Be in It To Win It?"  ...

Some Midday Observations

"Every little swallow, every chick-a-dee Every little bird in the tall oak tree The wise old owl, the big black crow Flappin' their wings signin' "go bird, go" Rockin' robin, (tweet-tweet-tweet) Rock-rock-rockin' robin' (tweet-tweedilly-tweet) Go ro...

Takeaways and Observations (2:30 p.m. Edition)

"It aint the heat, its the humility." - Yogi Berra With 90 minutes to go in the trading session volatility is getting crushed and, arguably, euphoria is advancing as fear has left the building. Leadership remains narrow as the largest tech stocks ((...

The Good, the Bad and the Ugly (Mid-Afternoon Edition)

"It's not a joke, it's a rope, Tuco. Now I want you to get up there and put your head in that noose." -- Blondie, " The Good, the Bad and the Ugly" No "Takeaways" today as I have to prepare for my Tulane trip. So let's move to the abbreviated Monarc...

The Good, the Bad and the Ugly (Mid-Afternoon Edition)

"It's not a joke, it's a rope, Tuco. Now I want you to get up there and put your head in that noose." -- Blondie, " The Good, the Bad and the Ugly" No "Takeaways" today as its vacation time at the Kass household and I want to take a swim with my fam...

The Good, the Bad and the Ugly (EarlyAfternoon Edition)

"It's not a joke, it's a rope, Tuco. Now I want you to get up there and put your head in that noose." -- Blondie, " The Good, the Bad and the Ugly" No "Takeaways" today as I want to spend some time with my family right after the close. So let's move...

Sage Defies Adversity on Its Way Up

Sage Defies Adversity on Its Way Up

The stock keeps moving upwards, despite worries over pricing in biotech.

Takeaways & Observations

Risk happens fast.  Most don't short and shouldn't short -- it's a game that requires volumes of risk control.  However, I would continue to maintain well above-average cash positions.  Today was not a benign event, in my view.  Nor was it likely a ...

Takeaways & Observations

I wanted to start by congratulating El Capitan for his 12th anniversary for Mad Money tonight. Like the Energizer Bunny, he keeps going and going...  HIgh yield gets junky -- despite protestations from Merrill's junk department! I have been warning ...

My Takeaways and Observatons

"As to the markets, it trades like participants are sleeping off hangovers from partying hard during last night's Super Bowl thriller." -- "Is Another Lesson Soon to be Learned?"   With such little price action it seemed like a snore fest (see above...

My Takeaways and Observations

The market pushed back presumably after it digested the inaugural speech and absorbed the marches around the world.   I don't believe the new president will be market and economy friendly.    The reflation trade is in question today.  And I remain b...

My Takeaways and Observations

"Who you tryin' to get crazy with, 'ese? Don't you know I'm loco?..." -- Cypress Hill, Insane in the Brain 2017 will be the year of "The Dude."    My favorite large-cap long Allergan  and short Caterpillar   for next year.  AGN closed up by $4(!) wh...